FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sarah Walker

Research Profile

Disorders

HIV Infections

Chemicals & Drugs

Procedures

Living Beings

Concepts & Ideas

Geographic Areas

Physiology

Viral Drug Resistance

Co-author Network

Publications

TOP 3
A Sarah Walker; Mark H Wilcox; David H Wyllie; Derrick W Crook; Kate E Dingle; David W Eyre; John Finney; David Griffiths; Sarah Oakley; Lily O'Connor; Tim E A Peto; Brian Shine; Alison Vaughan
Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.
Nicole E Stoesser; A Sarah Walker; Derrick W Crook; David W Eyre; Jessica Martin; Damian Mawer; Timothy E A Peto; Mark H Wilcox
Risk factors for Clostridium difficile acquisition in infants: importance of study design.
A Sarah Walker; Mark H Wilcox; Derrick W Crook; David W Eyre; Tim E A Peto
Regarding "clostridium difficile ribotype does not predict severe infection".

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sarah Walker (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: A Sarah Walker; Mark H Wilcox; David H Wyllie; Derrick W Crook; Kate E Dingle; David W Eyre; John Finney; David Griffiths; Sarah Oakley; Lily O'Connor; Tim E A Peto; Brian Shine; Alison Vaughan
Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(11):1589-600.
2013: Nicole E Stoesser; A Sarah Walker; Derrick W Crook; David W Eyre; Jessica Martin; Damian Mawer; Timothy E A Peto; Mark H Wilcox
Risk factors for Clostridium difficile acquisition in infants: importance of study design.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(11):1680-1.
2013: A Sarah Walker; Mark H Wilcox; Derrick W Crook; David W Eyre; Tim E A Peto
Regarding "clostridium difficile ribotype does not predict severe infection".
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(12):1845-6.
2013: David W Eyre; David Griffiths; Tim E A Peto; A Sarah Walker; Derrick W Crook; Madeleine L Cule; Daniel J Wilson
Detection of Mixed Infection from Bacterial Whole Genome Sequence Data Allows Assessment of Its Role in Clostridium difficile Transmission.
PLoS computational biology 2013;9(5):e1003059.
2013: Richard Katuramu; Adeodata Kekitiinwa; Peter Mugyenyi; Paula Munderi; Victor Musiime; Philippa Musoke; Patricia Nahirya-Ntege; Bethany Naidoo-James; Kusum Nathoo; Andrew J Prendergast; Margaret Thomason; Constance Tumusiime; Tichaona Vhembo; A Sarah Walker; Sabrina Bakeera-Kitaka; Mutsa Bwakura-Dangarembizi; Adrian Cook; Jane Crawley; Diana M Gibb
Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.
Lancet 2013;381(9875):1391-403.
2013: Andrew G B Thompson; A Sarah Walker; Marie-Claire Porter; Peter Rudge; John Collinge; Liz Ford; Zoe Fox; Gosala S Gopalakrishnan; Michele Gorham; Jessica Lowe; Ana Lukic; Simon Mead
The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies.
Brain : a journal of neurology 2013;136(Pt 4):1116-27.
2013: Kate E Dingle; David W Eyre; Warren N Fawley; Tanya Golubchik; David Griffiths; Derek W Hood; Camilla L C Ip; Keith Jolley; Timothy E Peto; Alison Vaughan; A Sarah Walker; Mark H Wilcox; M Azim Ansari; Elizabeth M Batty; Rory Bowden; Xavier Didelot; Derrick W Crook
Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large-scale whole-genome sequencing.
The Journal of infectious diseases 2013;207(4):675-86.
2013: Timothy M Walker; Daniel J Wilson; E Grace Smith; A Sarah Walker; Rory Bowden; Derrick W Crook; Martin J Dedicoat; Jason T Evans; David W Eyre; Ruth H Harrell; David Harris; Peter M Hawkey; Camilla L C Ip; Georgia Kapatai; Philip Monk; Julian Parkhill; Tim E A Peto
Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study.
The Lancet infectious diseases 2013;13(2):137-46.
2013: David W Eyre; Warren N Fawley; Jane Freeman; David Griffiths; Tim E A Peto; Alison Vaughan; A Sarah Walker; Simon D Baines; Caroline H Chilton; Derrick W Crook; Mark H Wilcox
Short-Term Genome Stability of Serial Clostridium difficile Ribotype 027 Isolates in an Experimental Gut Model and Recurrent Human Disease.
PloS one 2013;8(5):e63540.
2013: Charles F Gilks; Ruth L Goodall; Heiner Grosskurth; James Hakim; Elly Katabira; Cissy Kityo; Peter Mugyenyi; Paula Munderi; Andrew Reid; A Sarah Walker; Diana M Gibb
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.
PloS one 2013;8(2):e57580.
2013: Katherine Donegan; Di M Gibb; Ali Judd; Hermione Lyall; Esse N Menson; Andrew Riordan; Delane Shingadia; Pat Tookey; Gareth Tudor-Williams; A Sarah Walker; Karina Butler; Katja Doerholt
Lopinavir dosing in HIV-infected children in the United Kingdom and Ireland.
The Pediatric infectious disease journal 2013;32(1):45-50.
2012: A Sarah Walker; Diana M Gibb; Charles F Gilks; James Hakim; Elly Katabira; Addy Kekitiinwa; Cissy Kityo; Peter Mugyenyi; Paula Munderi; Patricia Nahirya-Ntege; Kusum J Nathoo; Andrew J Prendergast
Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(12):1707-18.
2012: Quirine Fillekes; Diana M Gibb; Desiré Kabamba; Chipepo Kankasa; Veronica Mulenga; Margaret J Thomason; A Sarah Walker; Chifumbe Chintu; Adrian Cook; Alex Ferrier; David M Burger
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
AIDS (London, England) 2012;26(14):1795-800.
2012: Derrick W Crook; Roberto Esposito; Sherwood L Gorbach; Yin Kean; Thomas J Louie; Mark A Miller; Timothy E A Peto; Nicole E Stoesser; A Sarah Walker; Karl Weiss; Bernadette C Young; Brian J Angus; Oliver A Cornely
Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 2():S93-103.
2012: David W Eyre; John Finney; David Griffiths; Lily O'Connor; Timothy E A Peto; Alison Vaughan; A Sarah Walker; Mark H Wilcox; David Wyllie; Derrick W Crook; Kate E Dingle
Predictors of first recurrence of Clostridium difficile infection: implications for initial management.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55 Suppl 2():S77-87.
2012: J Mirjam Oudijk; A Sarah Walker; Chifumbe Chintu; Adrian Cook; Diana M Gibb; Helen McIlleron; Concepta Merry; Veronica Mulenga; David M Burger
Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment.
AIDS (London, England) 2012;26(12):1523-8.
2012: Joanna Lewis; A Sarah Walker; Nigel Klein; Robin Callard
CD31+ cell percentage correlation with speed of CD4+ T-cell count recovery in HIV-infected adults is reversed in children: higher thymic output may be responsible.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;55(2):304-7; author reply 307.
2012: Iryna Schlackow; Nicole Stoesser; A Sarah Walker; David H Wyllie; Derrick W Crook; Tim E A Peto
Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999-2011.
The Journal of antimicrobial chemotherapy 2012;67(6):1514-24.
2012: Eva P Muro; Rob Schuurman; Andre J A M van der Ven; A Sarah Walker; Wil Dolmans; Quirine Fillekes; Diana M Gibb; Elton R Kisanga; Rafaëlla F A L'homme; Godfrey Mariki; Susan C Aitken; David M Burger
Intrapartum single-dose carbamazepine reduces nevirapine levels faster and may decrease resistance after a single dose of nevirapine for perinatal HIV prevention.
Journal of acquired immune deficiency syndromes (1999) 2012;59(3):266-73.
2012: Joanna Lewis; A Sarah Walker; Hannah Castro; Anita De Rossi; Carlo Giaquinto; Diana M Gibb; Nigel Klein; Robin Callard
Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution.
The Journal of infectious diseases 2012;205(4):548-56.
2012: A Sarah Walker; Mark H Wilcox; David H Wyllie; Ali Vaughan; Derrick W Crook; Kate E Dingle; David W Eyre; John Finney; David Griffiths; Rosalind M Harding; Lily O'Connor; Tim E A Peto
Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.
PLoS medicine 2012;9(2):e1001172.
2012: P Kasirye; Addy Kekitiinwa; L Kendall; T Mhute; P Nahirya-Ntege; W Snowden; M Ssenyonga; C Tumusiime; A Sarah Walker; K K Adkison; Sabrina Bakeera-Kitaka; D M Burger; Diana M Gibb
Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.
Clinical pharmacology and therapeutics 2012;91(2):272-80.
2012: Guy E Thwaites; Robert Tilley; M Estée Török; A Sarah Walker; John Williams; Peter Wilson; Sarah Wyllie; Cressida Auckland; Gavin Barlow; Richard Cunningham; Gerry Davies; Jonathan D Edgeworth; Julia Greig; Susan Hopkins; Neil Jenkins; Dakshika Jeyaratnam; Martin Llewelyn; Sarah Meisner; Emmanuel Nsutebu; Tim Planche; Robert C Read; Matthew Scarborough; Marta Soares
Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.
Trials 2012;13():241.
2012: Iryna Schlackow; Ali Vaughan; A Sarah Walker; Derrick W Crook; Kate Dingle; John Finney; Martin J Gill; David Griffiths; Sarah Oakley; Tim E A Peto; David H Wyllie
Surveillance of infection severity: a registry study of laboratory diagnosed Clostridium difficile.
PLoS medicine 2012;9(7):e1001279.
2012: Charles F Gilks; Pontiano Kaleebu; Ronnie Kasirye; Ben Kikaire; Ivan Mambule; Hellen Musana; Deenan Pillay; Andrew Reid; Val Robertson; Moira Spyer; Francis Ssali; A Sarah Walker; David L Yirrell; David T Dunn; Diana M Gibb
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).
Antiviral therapy 2012;17(7):1363-73.
2012: David W Eyre; Tanya Golubchik; N Claire Gordon; Camilla L C Ip; Angela M Kearns; Rochelle Lay; Lily O'Connor; John Paul; Tim E A Peto; Paolo Piazza; Angela Shaw; A Sarah Walker; Mark H Wilcox; Daniel J Wilson; Elizabeth M Batty; Rory Bowden; David Buck; Xavier Didelot; Peter J Donnelly; Derrick W Crook
A pilot study of rapid benchtop sequencing of Staphylococcus aureus and Clostridium difficile for outbreak detection and surveillance.
BMJ open 2012;2(3):.
2012: Diana M Gibb; Charles F Gilks; Heiner Grosskurth; James Hakim; Hilda Kizito; Hope Kyomugisha; Paula Munderi; Phillipa Musoke; Ruth Nalumenya; Kusum Nathoo; Elizabeth C Russell; Moira Spyer; Dinah Tumukunde; A Sarah Walker; Eva Zalwango; Ennie Chidziva
Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
PLoS medicine 2012;9(5):e1001217.
2012: Antonieta Medina Lara; Lazarus Muchabaiwa; Peter Mugyenyi; Ruben E Mujica Mota; Paula Munderi; Barbara Nyanzi Wakaholi; Andrew Reid; Francis Ssali; A Sarah Walker; Jovita Amurwon; Abdel G Babiker; Janet Darbyshire; Diana M Gibb; Charles F Gilks; Heiner Grosskurth; James Hakim; Ronnie Kasirye; Elly Katabira; Jesse Kigozi; Cissy Kityo
Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
PloS one 2012;7(4):e33672.
2012: Katherine L Donegan; David Dunn; Diana M Gibb; Ali Judd; Hermione Lyall; Esse N Menson; Deenan Pillay; Gareth Tudor-Williams; A Sarah Walker
The prevalence of darunavir-associated mutations in HIV-1-infected children in the UK.
Antiviral therapy 2012;17(4):599-603.
2011: Quirine Fillekes; Diana M Gibb; Rosette Keishanyu; Lindsay Kendall; Joseph Lutakome; Eva Natukunda; A Sarah Walker; Jackie Balungi; David M Burger; Mutsa Bwakura-Dangarembizi; Alex Ferrier
Pediatric underdosing of efavirenz: a pharmacokinetic study in Uganda.
Journal of acquired immune deficiency syndromes (1999) 2011;58(4):392-8.
2011: Nicole Stoesser; Alison Vaughan; A Sarah Walker; Derrick W Crook; Rowena Fung; David Griffiths; Rosalind M Harding; Melina Kachrimanidou; Satish Keshav; Tim E Peto; Kate E Dingle
Molecular epidemiology of Clostridium difficile strains in children compared with that of strains circulating in adults with Clostridium difficile-associated infection.
Journal of clinical microbiology 2011;49(11):3994-6.
2011: Andrew Prendergast; A Sarah Walker; Veronica Mulenga; Chifumbe Chintu; Diana M Gibb
Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(7):953-6.
2011: Abdel Babiker; Hannah Castro nee Green; Alexandra Compagnucci; Susan Fiscus; Carlo Giaquinto; Diana M Gibb; Lynda Harper; Linda Harrison; Michael Hughes; Ross McKinney; Ann Melvin; Lynne Mofenson; Yacine Saidi; M Elizabeth Smith; Gareth Tudor-Williams; A Sarah Walker
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
The Lancet infectious diseases 2011;11(4):273-83.
2011: A Sarah Walker; Diana M Gibb
Monitoring of highly active antiretroviral therapy in HIV infection.
Current opinion in infectious diseases 2011;24(1):27-33.
2011: Paula Munderi; Wendy B Snowden; A Sarah Walker; Cissy Kityo; Michael Mosteller; Geoffrey Kabuye; Navdeep K Thoofer; Francis Ssali; Charles F Gilks; Arlene R Hughes
Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART.
Tropical medicine & international health : TM & IH 2011;16(2):200-4.
2011: Wolfgang Stöhr; A Sarah Walker; Diana M Gibb; Charles F Gilks; Heiner Grosskurth; James Hakim; Cissy Kityo; Ivan Mambule; Paula Munderi; Andrew Reid; Francis Ssali
Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa.
Antiviral therapy 2011;16(7):1011-20.
2011: David H Wyllie; John Finney; Ruth Miller; Catrin Moore; Lily O'Connor; Tim E A Peto; Iryna Schlackow; A Sarah Walker; Susan R Williamson; Derrick W Crook
Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification.
BMJ open 2011;1(1):e000160.
2011: Kate E Dingle; David Griffiths; Xavier Didelot; Jessica Evans; Alison Vaughan; Melina Kachrimanidou; Nicole Stoesser; Keith Jolley; Tanya Golubchik; Rosalind M Harding; T E A Peto; Warren Fawley; A Sarah Walker; Mark Wilcox; Derrick W Crook
Clinical Clostridium difficile: clonality and pathogenicity locus diversity.
PloS one 2011;6(5):e19993.
2011: Jessica E Haberer; Adrian Cook; A Sarah Walker; Marjorie Ngambi; Alex Ferrier; Veronica Mulenga; Cissy Kityo; Margaret Thomason; Desiree Kabamba; Chifumbe Chintu; Diana M Gibb; David R Bangsberg
Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.
PloS one 2011;6(4):e18505.
2011: John Finney; A Sarah Walker; Tim E A Peto; David H Wyllie
An efficient record linkage scheme using graphical analysis for identifier error detection.
BMC medical informatics and decision making 2011;11():7.
2011: Dona Foster; A Sarah Walker; John Paul; David Griffiths; Kyle Knox; T E A Peto; Derrick W Crook
Reduction in invasive pneumococcal disease following implementation of the conjugate vaccine in the Oxfordshire region, England.
Journal of medical microbiology 2011;60(Pt 1):91-7.
2010: Veronica Mulenga; A Cook; A Sarah Walker; D Kabamba; C Chijoka; A Ferrier; C Kalengo; C Kityo; C Kankasa; David Burger; M Thomason; Chifumbe Chintu; Diana M Gibb
Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;51(9):1081-9.
2010: Ravindra K Gupta; Deborah Ford; Veronica Mulenga; A Sarah Walker; Desire Kabamba; Moxmalama Kalumbi; Paul R Grant; Alexander Ferrier; Deenan Pillay; Diana M Gibb; Chifumbe Chintu
Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine.
The Pediatric infectious disease journal 2010;29(8):e57-62.
2010: Cissy Kityo; A Sarah Walker; L Dickinson; Fredrick Lutwama; J Kayiwa; Francis Ssali; R Nalumenya; D Tumukunde; Paula Munderi; A Reid; Charles F Gilks; Diana M Gibb; Saye Khoo
Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adults.
Antimicrobial agents and chemotherapy 2010;54(7):2965-73.
2010: David Burger; Fiona Ewings; Desiré Kabamba; Rafaëlla F A L'homme; Veronica Mulenga; Chipepo Kankasa; Margaret Thomason; Diana M Gibb; Chifumbe Chintu; A Sarah Walker
Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tablets.
Therapeutic drug monitoring 2010;32(3):369-72.
2010: Paula Munderi; A Sarah Walker; C Kityo; Abdel G Babiker; Francis Ssali; A Reid; Janet Darbyshire; Heiner Grosskurth; Peter Mugyenyi; Diana M Gibb; Charles F Gilks
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
HIV medicine 2010;11(5):334-44.
2010: A Sarah Walker; D Ford; Charles F Gilks; Paula Munderi; F Ssali; A Reid; E Katabira; Heiner Grosskurth; P Mugyenyi; James Hakim; Janet Darbyshire; Diana M Gibb; Abdel G Babiker
Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
Lancet 2010;375(9722):1278-86.
2010: David Griffiths; Warren Fawley; Melina Kachrimanidou; Rory Bowden; Derrick W Crook; Rowena Fung; Tanya Golubchik; Rosalind M Harding; Katie J M Jeffery; Keith Jolley; Richard Kirton; Tim E Peto; Gareth Rees; Nicole Stoesser; Alison Vaughan; A Sarah Walker; Bernadette C Young; Mark Wilcox; Kate E Dingle
Multilocus sequence typing of Clostridium difficile.
Journal of clinical microbiology 2010;48(3):770-8.
2010: Victor Musiime; Lindsay Kendall; Sabrina Bakeera-Kitaka; Wendy B Snowden; Florence Odongo; Margaret Thomason; Philippa Musoke; Kimberly Adkison; David Burger; Peter Mugyenyi; Adeodata Kekitiinwa; Diana M Gibb; A Sarah Walker
Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.
Antiviral therapy 2010;15(8):1115-24.
2010: Nicaise Ndembi; Nicasie Ndembi; Ruth L Goodall; David T Dunn; Adele McCormick; Andy Burke; Fred Lyagoba; Paula Munderi; Pauline Katundu; Cissy Kityo; Val Robertson; David L Yirrell; A Sarah Walker; Diana M Gibb; Charles F Gilks; Pontiano Kaleebu; Deenan Pillay
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.
The Journal of infectious diseases 2010;201(1):106-13.
2008: Giota Touloumi; Nikos Pantazis; Heide A Stirnadel; A Sarah Walker; Faroudy Boufassa; Philippe Vanhems; Kholoud Porter
Rates and determinants of virologic and immunological response to HAART resumption after treatment interruption in HIV-1 clinical practice.
Journal of acquired immune deficiency syndromes (1999) 2008;49(5):492-8.
2008: Addy Kekitiinwa; Katherine J Lee; A Sarah Walker; Albert Maganda; Katja Doerholt; Sabrina B Kitaka; Alice Asiimwe; Ali Judd; Philippa Musoke; Diana M Gibb
Differences in factors associated with initial growth, CD4, and viral load responses to ART in HIV-infected children in Kampala, Uganda, and the United Kingdom/Ireland.
Journal of acquired immune deficiency syndromes (1999) 2008;49(4):384-92.
2008: William Burman; Mark F Cotton; Diana M Gibb; A Sarah Walker; Andrew A Vernon; Peter R Donald
Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens.
PLoS medicine 2008;5(8):e176.
2008: Sylvia K Muyingo; A Sarah Walker; Andy Reid; Paula Munderi; Diana M Gibb; Francis Ssali; Jonathan Levin; Elly Katabira; Charlie Gilks; Jim Todd
Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.
Journal of acquired immune deficiency syndromes (1999) 2008;48(4):468-75.
2008: Andrew Reid; Wolfgang Stöhr; A Sarah Walker; Ian G Williams; Cissy Kityo; Peter Hughes; Andrew Kambugu; Charles F Gilks; Peter Mugyenyi; Paula Munderi; James Hakim; Diana M Gibb
Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(8):1271-81.
2008: Dona Foster; Kyle Knox; A Sarah Walker; D T Griffiths; Hazel Moore; Elizabeth Haworth; T E A Peto; Angela B Brueggemann; Derrick W Crook
Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.
Journal of medical microbiology 2008;57(Pt 4):480-7.
2008: Máirín Ryan; Susan Griffin; Bona Chitah; A Sarah Walker; Veronica Mulenga; Donald Kalolo; Neil Hawkins; Concepta Merry; Michael G Barry; Chifumbe Chintu; Mark J Sculpher; Diana M Gibb
The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.
AIDS (London, England) 2008;22(6):749-57.
2008: Rafaëlla F A L'homme; Desiré Kabamba; Fiona M Ewings; Veronica Mulenga; Chipepo Kankasa; Margaret J Thomason; A Sarah Walker; Chifumbe Chintu; David Burger; Diana M Gibb
Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.
AIDS (London, England) 2008;22(5):557-65.
2008: A Sarah Walker; David J Spiegelhalter; Derrick W Crook; David Wyllie; James Morris; Tim E A Peto
Fairness of financial penalties to improve control of Clostridium difficile.
BMJ (Clinical research ed.) 2008;337():a2097.
2008: Wolfgang Stöhr; A Sarah Walker; Paula Munderi; Stefano Tugume; Charles F Gilks; Janet Darbyshire; James Hakim
Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-Gault and Modification of Diet in Renal Disease formulae.
Antiviral therapy 2008;13(6):761-70.
2007: David H Wyllie; A Sarah Walker; T E A Peto; Derrick W Crook
Hospital exposure in a UK population, and its association with bacteraemia.
The Journal of hospital infection 2007;67(4):301-7.
2007: A Sarah Walker; Veronica Mulenga; Deborah Ford; Desire Kabamba; Frederick Sinyinza; Chipepo Kankasa; Chifumbe Chintu; Diana M Gibb
The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(10):1361-7.
2007: Hannah Green; Diana M Gibb; A Sarah Walker; Deenan Pillay; K Butler; F Candeias; Guido Gattinara Castelli; Alexandra Compagnucci; Marinella Della Negra; Anita De Rossi; C Feiterna-Sperling; Carlo Giaquinto; Lynda Harper; J Levy; Y Saidi; Uwe Wintergerst
Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
AIDS (London, England) 2007;21(8):947-55.
2007: Ben Kikaire; Saye Khoo; A Sarah Walker; Francis Ssali; Paula Munderi; Letitia Namale; Andrew Reid; Diana M Gibb; Peter Mugyenyi; Heiner Grosskurth
Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.
AIDS (London, England) 2007;21(6):733-7.
2007: Veronica Mulenga; Deborah Ford; A Sarah Walker; Darlington Mwenya; James Mwansa; Frederick Sinyinza; Kennedy Lishimpi; Andrew Nunn; Stephen Gillespie; Alimuddin Zumla; Chifumbe Chintu; Diana M Gibb
Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.
AIDS (London, England) 2007;21(1):77-84.
2007: Katherine J Lee; Delane Shingadia; Deenan Pillay; A Sarah Walker; Andrew Riordan; Esse N Menson; Trinh Duong; Gareth Tudor-Williams; Diana M Gibb
Transient viral load increases in HIV-infected children in the U.K. and Ireland: what do they mean?
Antiviral therapy 2007;12(6):949-56.
2007: Jane C Ellis; Rafaëlla F A L'homme; Fiona M Ewings; Veronica Mulenga; Frank Bell; Regina Chileshe; Elizabeth Molyneux; Julia Abernethy; Joep J G van Oosterhout; Chifumbe Chintu; A Sarah Walker; Diana M Gibb; David Burger
Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.
Antiviral therapy 2007;12(2):253-60.
2006: A Sarah Walker; Veronica Mulenga; Frederick Sinyinza; Kennedy Lishimpi; Andrew Nunn; Chifumbe Chintu; Diana M Gibb
Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
Journal of acquired immune deficiency syndromes (1999) 2006;42(5):637-45.
2006: Marthe LePrevost; Hannah Green; Jacquie Flynn; Stephen Head; Margaret Clapson; Hermione Lyall; Vas Novelli; Laura Farrelly; A Sarah Walker; David Burger; Diana M Gibb
Adherence and acceptability of once daily Lamivudine and abacavir in human immunodeficiency virus type-1 infected children.
The Pediatric infectious disease journal 2006;25(6):533-7.
2006: Esse N Menson; A Sarah Walker; Mike Sharland; Carole Wells; Gareth Tudor-Williams; F Andrew I Riordan; E G Hermione Lyall; Diana M Gibb
Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study.
BMJ (Clinical research ed.) 2006;332(7551):1183-7.
2006: Katja Doerholt; Trinh Duong; Pat A Tookey; Karina Butler; Hermione Lyall; Mike Sharland; Vas Novelli; Andrew Riordan; David Dunn; A Sarah Walker; Diana M Gibb
Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy.
The Pediatric infectious disease journal 2006;25(5):420-6.
2006: Francis Ssali; Wolfgang Stöhr; Paula Munderi; Andrew Reid; A Sarah Walker; Diana M Gibb; Peter Mugyenyi; Cissy Kityo; Heiner Grosskurth; James Hakim; Helen Byakwaga; Elly Katabira; Janet Darbyshire; Charles F Gilks
Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
Antiviral therapy 2006;11(6):741-9.
2006: Hannah Green; Diana M Gibb; Alexandra Compagnucci; Vania Giacomet; Anita De Rossi; Lynda Harper; Yacine Saïdi; Guido Gattinara Castelli; Deenan Pillay; Abdel G Babiker; Jean-Pierre Aboulker; Hermione Lyall; Lee Bacheler; A Sarah Walker; Marianne Debré; Raffaella Rosso; David Burger; Marinella Della Negra; David T Dunn; Carlo Giaquinto
A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial.
Antiviral therapy 2006;11(7):857-67.
2005: Anita De Rossi; A Sarah Walker; Davide De Forni; Nigel Klein; Diana M Gibb
Relationship between changes in thymic emigrants and cell-associated HIV-1 DNA in HIV-1-infected children initiating antiretroviral therapy.
Antiviral therapy 2005;10(1):63-71.
2004: Esse N Menson; A Sarah Walker; Diana M Gibb
Clinical trials in children.
Lancet 2004;364(9452):2176-7.
2004: Chifumbe Chintu; G J Bhat; A Sarah Walker; Veronica Mulenga; Frederick Sinyinza; Kennedy Lishimpi; Laura Farrelly; N Kaganson; Alimuddin Zumla; S H Gillespie; Andrew Nunn; Diana M Gibb
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.
Lancet 2004;364(9448):1865-71.
2004: A Sarah Walker; Katja Doerholt; Mike Sharland; Diana M Gibb
Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study.
AIDS (London, England) 2004;18(14):1915-24.
2004: Caroline A Sabin; A Sarah Walker; David Dunn
HIV/HCV coinfection, HAART, and liver-related mortality.
Lancet 2004;364(9436):757-8; author reply 758.
2004: bruno ledergerber; Jens D Lundgren; A Sarah Walker; Caroline Sabin; Amy Justice; Peter Reiss; Cristina Mussini; Ferdinand Wit; Antonella d'Arminio Monforte; Rainer Weber; Gregory Fusco; Schlomo Staszewski; Matthew Law; Hogg Robert; Fiona Lampe; M John Gill; Francesco Castelli; Andrew N Phillips
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.
Lancet 2004;364(9428):51-62.
2004: Krishnan Bhaskaran; Deenan Pillay; A Sarah Walker; Martin Fisher; David Hawkins; Richard Gilson; Ken McLean; Kholoud Porter
Do patients who are infected with drug-resistant HIV have a different CD4 cell decline after seroconversion? An exploratory analysis in the UK Register of HIV Seroconverters.
AIDS (London, England) 2004;18(10):1471-3.
2004: Diana M Gibb; Trinh Duong; Veronica A Leclezio; A Sarah Walker; Gwenda Verweel; David T Dunn
Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type 1 infection.
The Pediatric infectious disease journal 2004;23(5):446-50.
2004: Krishnan Bhaskaran; Ray Brettle; Kholoud Porter; A Sarah Walker
Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors.
AIDS (London, England) 2004;18(4):673-81.
2004: A Sarah Walker; Ian R White; Abdel G Babiker
Parametric randomization-based methods for correcting for treatment changes in the assessment of the causal effect of treatment.
Statistics in medicine 2004;23(4):571-90.
2004: Andrew N Phillips; A Sarah Walker
Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.
AIDS (London, England) 2004;18(3):365-70.
2004: Jean-Pierre Aboulker; Abdel G Babiker; Marie-Laure Chaix; Alexandra Compagnucci; Janet Darbyshire; M Debré; Albert Faye; Carlo Giaquinto; Diana M Gibb; Lynda Harper; Yacine Saïdi; A Sarah Walker
Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.
AIDS (London, England) 2004;18(2):237-45.
2003: Kholoud Porter; Abdel Babiker; Krishnan Bhaskaran; Janet Darbyshire; Patrizio Pezzotti; Kholoud Porter; A Sarah Walker
Determinants of survival following HIV-1 seroconversion after the introduction of HAART.
Lancet 2003;362(9392):1267-74.
2003: Abdel G Babiker; Janet Darbyshire; Patrizio Pezzotti; Kholoud Porter; Maria Prins; Caroline Sabin; A Sarah Walker
Short-term CD4 cell response after highly active antiretroviral therapy initiated at different times from seroconversion in 1,500 seroconverters.
Journal of acquired immune deficiency syndromes (1999) 2003;32(3):303-10.
2002: Diana M Gibb; A Sarah Walker; Steve Kaye; Anita De Rossi; Mounir Ait-Khaled; Deenan Pillay; Maria Angeles Muñoz-Fernandez; Clive Loveday; Alexandra Compagnucci; David T Dunn; Abdel G Babiker
Evolution of antiretroviral phenotypic and genotypic drug resistance in antiretroviral-naive HIV-1-infected children treated with abacavir/lamivudine, zidovudine/lamivudine or abacavir/zidovudine, with or without nelfinavir (the PENTA 5 trial).
Antiviral therapy 2002;7(4):293-303.
2002: Anita De Rossi; A Sarah Walker; Davide De Forni; Diana M Gibb
Biphasic decay of cell-associated HIV-1 DNA in HIV-1-infected children on antiretroviral therapy.
AIDS (London, England) 2002;16(14):1961-3.
2002: Deenan Pillay; A Sarah Walker; Diana M Gibb; Anita De Rossi; Steve Kaye; Mounir Ait-Khaled; Maria Muñoz-Fernandez; Abdel G Babiker
Impact of human immunodeficiency virus type 1 subtypes on virologic response and emergence of drug resistance among children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial.
The Journal of infectious diseases 2002;186(5):617-25.
2002: Anita De Rossi; A Sarah Walker; Nigel Klein; Davide De Forni; Doug King; Diana M Gibb
Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial.
The Journal of infectious diseases 2002;186(3):312-20.
2001: A G Babiker; T E A Peto; K Porter; A Sarah Walker; Janet Darbyshire
Age as a determinant of survival in HIV infection.
Journal of clinical epidemiology 2001;54 Suppl 1():S16-21.
2001: A Sarah Walker; Abdel G Babiker; Diana M Gibb; David T Dunn
Mother-to-child transmission of HIV-1 and infant feeding practice.
AIDS (London, England) 2001;15(10):1327-8.
2000: A Sarah Walker; A G Babiker; Janet Darbyshire
Analysis of multivariate failure-time data from HIV clinical trials.
Controlled clinical trials 2000;21(2):75-93.
1998: A Sarah Walker; T E A Peto; A G Babiker; Janet Darbyshire
Markers of HIV infection in the Concorde trial. Concorde Co-ordinating Committee.
QJM : monthly journal of the Association of Physicians 1998;91(6):423-38.